TSOI Projected Dividend Yield
Therapeutic Solutions International Inc ( OTCBB : TSOI )Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Co. is developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. Co.'s product, NanoStilbene™ PKE, is prepared by low-energy emulsification which allows for solubility, stability, and the release performance of pterostilbene nanoparticles. Co. owns rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury. The stem cell licensed, termed JadiCell possesses features of mesenchymal stem cells. 20 YEAR PERFORMANCE RESULTS |
TSOI Dividend History Detail TSOI Dividend News TSOI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |